Products labeled as sterile were distributed, but may not have been sterilized.
Source facts
Action
The firm notified two consignees with the preliminary information by email on 03/22/2021 and followed with the official notice with the complete information on 04/08/2021 to all consignees. The letter requested that the consignee cease using the affected product and contact Biopsybell or a Biopsybell representative for product return/disposal and related replacement. Distributors were directed to identify those who received the product and notify them.
Initiated
2021-03-22
Root cause
Vendor change control
Terminated
2026-02-17
Distribution
US Nationwide distribution in the states MS and KY.
Recall number
Z-1642-2021
Recall status
Terminated
CDRH record ID
186909
FDA classified
2021-05-19
Recall event number
87696
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.